Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-25

Clinical Trial Update: Compassionate Use of Omegaven in Children [Phase 2, Phase 3]

View source ↗

Summary

A completed compassionate-use trial update for Omegaven in children with parenteral nutrition-associated cholestasis, with Phase 2 and Phase 3 activity and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: University of Oklahoma | Conditions: Total Parenteral Nutrition-induced Cholestasis, Cholestasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-11-25